cobicistat 150 MG / darunavir 800 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet
RxNorm concept 2049671, clinical drug (scd). Prescribable name: darunavir 800 MG / cobicistat 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet.
- RxCUI
- 2049671
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049671 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- emtricitabine 200 MG (SCDC, consists of)
- cobicistat 150 MG (SCDC, consists of)
- darunavir 800 MG (SCDC, consists of)
- tenofovir alafenamide 10 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- cobicistat 150 MG / darunavir 800 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Symtuza] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2049671 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049671 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2049671. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.